COMMUNIQUÉS West-GlobeNewswire

TRHC’s SinfoníaRx named a “Top Company to Work for in Arizona” for Third Year in a Row
11/06/2018
MOORESTOWN, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, announced today its subsidiary, SinfoníaRx, has earned [...]
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent for Use of Stem Cells to Treat Cancer and Autoimmune Disorders
11/06/2018
Patent Covers Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ:VTGN), a clinical-stage [...]
70% of Canadian Men’s Chronic Health Conditions are Caused by Lifestyle, not Genetics
11/06/2018
Earlier detection of diabetes and cardiovascular issues with preventive action can reverse and prevent disease. UBC spin-off, Molecular You, offers a solution VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE [...]
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Association for Professionals in Infection Control and Epidemiology Annual Conference June 13-15th
11/06/2018
The rise in difficult-to-treat super bugs spread from skin-to-skin contact stresses the need for thermometers that do not touch the patient DELRAY BEACH, Fla., June 11, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“ [...]
Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
11/06/2018
SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
The American Health Council Physician Board Welcomes Marvin Faulkner, DO, BA
11/06/2018
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Marvin Faulkner, DO, BA to its Board of Physicians for his outstanding contributions to the medical field. As a pain physician at [...]
Paratek Presents New Analysis from Combined Phase 3 Skin Infection Studies Highlighting Efficacy of Omadacycline in Treating Drug Resistant S. aureus at ASM Microbe 2018
11/06/2018
BOSTON, June 11, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors
11/06/2018
NEWTON, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
11/06/2018
MIAMI, June 11, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) today announced it has completed enrollment of 110 subjects in a Phase 2b dose escalation trial of OPK88003 to treat type 2 diabetes and obesity. [...]
Interpace Diagnostics Announces Coverage of Thyroid Testing by Blue Cross Blue Shield of Florida
11/06/2018
Florida’s Largest Health Plan Adds Coverage for ThyGenX ® and ThyraMIR ® PARSIPPANY, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully- [...]
Nkarta Therapeutics Announces Exclusive License to Natural Killer Cell Technology From National University of Singapore and St. Jude Children’s Research Hospital
11/06/2018
SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing Natural Killer (NK) immune cells to fight cancer, today announced that it has entered [...]
Retrotope Announces the Initiation of Expanded Access (Compassionate Use) Trials of RT001 in Two Neurodegenerative Disorders
11/06/2018
Late Onset Tay Sachs and Neuroserpinosis single-patient trials mark the fourth and fifth trials of Retrotope’s drug candidate in an untreated neurological disease LOS ALTOS, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- [...]
Natus Medical Comments on ISS Report
11/06/2018
Board Urges Shareholders to Vote on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss ISS Agrees Shareholders Should NOT Vote for Removal of Chairman Robert Gunst PLEASANTON, Calif. , June 11, [...]
International Endeavors Corporation Hires Marketing Director
11/06/2018
TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab [...]
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
11/06/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE [...]
Study published in Cancer Discovery Indicates that NY-ESO SPEAR T-cells are Long-lived, Self‑renewing, and Capable of Persistent Anti-Tumor Effects
11/06/2018
Data indicate that self-renewing pools of SPEAR T-cells can produce a continuous supply of effector cells capable of mediating sustained antitumor effects PHILADELPHIA and OXFORD, United Kingdom, June 11, 2018 (GLOBE [...]
Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference
11/06/2018
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction
11/06/2018
CAMPBELL, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that it has met the closing conditions, including Hart-Scott-Rodino review, [...]
MPX Completes Acquisition of Canadian Licensed Producer
11/06/2018
TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed the acquisition of 100% of the issued [...]

Pages